Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXC9QX
|
||||
| Drug Name |
(S)-N-(cyanomethyl)-4-methyl-2-((S)-1,1,1-trifluorohexan-2-ylamino)pentanamide
|
||||
| Synonyms |
CHEMBL206169
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C14H24F3N3O
|
||||
| Canonical SMILES |
CCCC[C@H](N[C@@H](CC(C)C)C(=O)NCC#N)C(F)(F)F
|
||||
| InChI |
InChI=1S/C14H24F3N3O/c1-4-5-6-12(14(15,16)17)20-11(9-10(2)3)13(21)19-8-7-18/h10-12,20H,4-6,8-9H2,1-3H3,(H,19,21)/t11-,12-/m0/s1
|
||||
| InChIKey |
VJBHFNIJBKVCJM-RYUDHWBXSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.